← Browse by Condition

Medical Condition

prostate cancer

Total Trials

86

Recruiting Now

86

Trial Phases

EARLY_Phase 1, Phase 1, Phase 2

NCT06756334 EARLY_Phase 1

Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Anhui Provincial Hospital

Precision-Based Genomics in Prostate Cancer

National Cancer Institute (NCI...

NCT05787587 Phase 1

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

IDEAYA Biosciences

NCT04700332 Phase 2

PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer

Hoag Memorial Hospital Presbyt...

Collection of Blood From Patients With Prostate Cancer

National Cancer Institute (NCI...

NCT06402357 Phase 2

High Intensity Focused Ultrasound in Prostate Cancer

University of Florida

Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.

Institut Bergonié

NCT05656573 Phase 1

CART-PSMA Cells for Advanced Prostate Cancer

Nova Therapeutics LLC

The Role of Levator Ani Muscle Reconstruction Technology in Urinary Incontinence Recovery

Peking University First Hospit...

Evaluating Tolerability of ePUHRT With Brachytherapy Boost

Indiana University

Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate Cancer

Norwegian University of Scienc...

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

Santa Chiara Hospital

NCT06237179 Phase 1, Phase 2

Behavioral Exercise Training to Reduce Cardiovascular Disease Risk

Virginia Commonwealth Universi...

NCT06780670 Phase 2, Phase 3

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

United States, Austr...

Novartis Pharmaceuticals

NCT06395753 Phase 2

A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer

United States, Belgi...

Debiopharm International SA

CV CARE: CardioVascular Care in PC Patients

Dana-Farber Cancer Institute

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

Proton Collaborative Group

Spa Therapy for Upper or Lower Limb Lymphoedema

Association Francaise pour la ...

Investigation of Impact of AI on Prostate Cancer Workflow

Case Comprehensive Cancer Cent...

Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer

University Health Network, Tor...

NCT02064673 Phase 3

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

NCT06441994 Phase 1

Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cancer

Osaka University

Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)

Singapore General Hospital

NCT06925737 Phase 3

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

United States, Argen...

Merck Sharp & Dohme LLC

NCT05803941 Phase 4

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

United States, Austr...

Novartis Pharmaceuticals

Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer

Henry Ford Health System

NCT07426094 Phase 2, Phase 3

PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer

Affidea Nu-med Center of Oncol...

Phase II Study of Single-Dose Image-Guided Radiotherapy (SDRT) for Prostate Cancer

Fundacao Champalimaud

NCT03424850 Phase 1, Phase 2

Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy

Washington University School o...

NCT06395519 Phase 1, Phase 2

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

858 Therapeutics, Inc.

MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days

Universitair Ziekenhuis Brusse...

Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy

National Cancer Institute (NCI...

Application of a Novel Biomarker Based on Plasma cfDNA Assay in the Early Diagnosis of Prostate Cancer

Shanghai Changzheng Hospital

Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer

Adam S. Kibel, MD

Mechanisms of Resistance to PSMA Radioligand Therapy

University of California, San ...

Micro-UltraSound In Cancer - Active Surveillance

United States, Canad...

University of Alberta

NCT06384222 Phase 2

Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone

Ivan de Kouchkovsky, MD

Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

University of Michigan Rogel C...

NCT05616650 Phase 2

Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor

National Cancer Institute (NCI...

Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

Dana-Farber Cancer Institute

NCT06096870 Phase 2

Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

National Cancer Institute (NCI...

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

Indiana University

NCT06397703 Phase 2

ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer

NYU Langone Health

NCT06440005 Phase 1

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Cognitive and Fusion Prostatic Biopsy

Menoufia University

NCT07163910 Phase 2

Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study

START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC

Instituto de Investigación en ...

Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate Cancer

Azienda Ospedaliero Universita...

AI-based Measurements of Tumour Burden in PSMA PET-CT

Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

Duke University

Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour

Nova Scotia Health Authority

Cost-utility of Focal HIFU vs Prostatectomy

France, Guadeloupe

University Hospital, Bordeaux

National Robotics-Assisted Radical Prostatectomy Database

Melbourne Health

NCT06001619 Phase 4

Prostate Medication, Metabolism and Gut Microbiota

Turku University Hospital

NCT05753566 Phase 2

Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer

The Affiliated Nanjing Drum To...

HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer

University of Kansas Medical C...

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Hospices Civils de Lyon

A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

United States, Austr...

McMaster University

Evaluating the Effectiveness of the Nurse Ned Clinic

University Health Network, Tor...

Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence System

Hospices Civils de Lyon

NCT05766371 Phase 2

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

University of California, San ...

Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.

Jules Bordet Institute

Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer Patients

Centre Hospitalier Universitai...

NCT05521412 Phase 1, Phase 2

EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T

Peter MacCallum Cancer Centre,...

The Effect of Pulsed Electromagnetic Field Therapy on Muscle Mass and Muscle Strength in Prostate Cancer Patients Treated With Androgen Deprivation Therapy

Chinese University of Hong Kon...

Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer

Peking University First Hospit...

Outcomes of Focal Ablation for Prostate Cancer

University of Texas Southweste...

Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life

University of Chicago

NCT04642027 Phase 3

PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy

University Medical Center Gron...

NCT07028853 Phase 3

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

United States, Argen...

NCT07339267 Phase 1

A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer

Astellas Pharma Global Develop...

Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System

Hospital Moinhos de Vento

SBRT Boost for Unfavorable Prostate Cancer'

MemorialCare Health System

NCT04887935 Phase 1

Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer

Washington University School o...

Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort

Northwell Health

NCT04585750 Phase 1, Phase 2

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

United States, Austr...

PMV Pharmaceuticals, Inc

NCT05381103 Phase 2, Phase 3

PSMA-PET to Guide Prostatectomy

Five Eleven Pharma, Inc.

NCT06059118 Phase 2

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Sidney Kimmel Comprehensive Ca...

NCT05974774 Phase 3

Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors

Denmark, France, Spa...

European Organisation for Rese...

EDRN Prostate MRI Biomarker Study

University of Michigan

NCT04212715 Phase 2

Prostate SABR With Intra-Prostatic SABR Boost

King Saud University

The Florida ASCENT Study

University of Florida

Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)

University of Lausanne Hospita...

NCT05864196 Phase 1

Two Fraction Prostate SBRT With DIL SIB

NYU Langone Health